CHRAC1 Antikörper (C-Term)
-
- Target Alle CHRAC1 Antikörper anzeigen
- CHRAC1 (Chromatin Accessibility Complex 1 (CHRAC1))
-
Bindungsspezifität
- C-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CHRAC1 Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (IHC), ELISA
- Kreuzreaktivität
- Human, Maus
- Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Immunogen
- Synthesized peptide derived from the C-terminal region of Human CHRAC15.
- Isotyp
- IgG
- Top Product
- Discover our top product CHRAC1 Primärantikörper
-
anti-Chromatin Accessibility Complex 1 (CHRAC1) (AA 1-131) antibody
CHRAC1 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Chromatin Accessibility Complex 1 (CHRAC1) (AA 1-96) antibodyCHRAC1 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 4E7 unconjugated
anti-Chromatin Accessibility Complex 1 (CHRAC1) (AA 1-131) antibodyCHRAC1 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 4B8 unconjugated
anti-Chromatin Accessibility Complex 1 (CHRAC1) (C-Term) antibodyCHRAC1 Reaktivität: Human, Maus WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Chromatin Accessibility Complex 1 (CHRAC1) (C-Term) antibodyCHRAC1 Reaktivität: Human, Affe, Pferd WB Wirt: Kaninchen Polyclonal unconjugated
anti-Chromatin Accessibility Complex 1 (CHRAC1) (AA 36-85) antibodyCHRAC1 Reaktivität: Human, Maus, Ratte, Affe, Schwein WB Wirt: Kaninchen Polyclonal unconjugated
anti-Chromatin Accessibility Complex 1 (CHRAC1) (AA 1-131) antibodyKO Validated CHRAC1 Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Chromatin Accessibility Complex 1 (CHRAC1) (Middle Region) antibodyCHRAC1 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Hund, Drosophila melanogaster WB Wirt: Kaninchen Polyclonal unconjugated
anti-Chromatin Accessibility Complex 1 (CHRAC1) (N-Term) antibodyCHRAC1 Reaktivität: Human, Maus, Ratte, Rind (Kuh) WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- IHC:1:100-1:300, ELISA:1:5000,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- CHRAC1 (Chromatin Accessibility Complex 1 (CHRAC1))
- Andere Bezeichnung
- CHRAC1 (CHRAC1 Produkte)
- Synonyme
- chrac1 antikoerper, CHRAC1 antikoerper, CHARC1 antikoerper, CHARC15 antikoerper, CHRAC-1 antikoerper, CHRAC-15 antikoerper, CHRAC15 antikoerper, YCL1 antikoerper, 2410152E03Rik antikoerper, 2810406L04Rik antikoerper, chromatin accessibility complex 1 antikoerper, chrac1 antikoerper, CHRAC1 antikoerper, Chrac1 antikoerper
- Hintergrund
- CHARC1 antibody, CHARC15 antibody, CHRAC-1 antibody, CHRAC-15 antibody, Chrac1 antibody, CHRAC15 antibody, CHRC1_HUMAN antibody, Chromatin accessibility complex 1 antibody, Chromatin accessibility complex 15 kDa protein antibody, Chromatin accessibility complex protein 1 antibody, DNA polymerase epsilon subunit p15 antibody, histone-fold protein CHRAC15 antibody, HuCHRAC15 antibody, YCL1 antibody
- UniProt
- Q9NRG0
-
